New Yaz Blood Clot Lawsuit Joins MDL against Bayer
By Robert J. Boumis
Latika Threatt of North Carolina has filed a Yaz lawsuit against Bayer over complications allegedly caused by their drospirenone-containing birth control pill.
According to her Yaz lawsuit, Threatt took the drug from 2009 until 2012. In February 2012, she suffered from a series of blood clots, which allegedly caused permanent, severe injuries.
The Yaz lawsuit alleges that Bayer knew, or reasonably should have known, about the risks of blood clots associated with this class of birth control pills, based on peer-reviewed studies, routine post-market surveillance and their own clinical trials. The text of the complaint cites several studies, including a 2003 paper entitled “Thromboembolism Associated with the New Contraceptive Yasmin, Yaz, Ocella and/or Beyaz,” published in the prestigious British Medical Journal (BMJ) that reported on the risk of blood clots and related complications associated with these drugs. Additionally, the Yaz lawsuit states that the U.S. Food & Drug Administration’s Adverse Event Reporting System (AERS) also contained reports of blood clots associated with these drugs.
The Yaz lawsuit further alleges that not only did Bayer not do enough to protect the public, but they also actively concealed the risks associated with this class of birth control pills. The Yaz side effects lawsuit asserts that Bayer concealed the fact that these drugs were not as safe as other forms of contraception, both from the FDA and the general public. Such concealment could prevent patients like Threatt and health care providers from having all of the information they needed to make informed medical decisions. The Yaz lawsuit asserts that Threatt would not have used this type of contraceptive had she been aware of the serious risks associated with these products.
The Yaz lawsuit is Latika Threatt v. Bayer Corporation, et al., Case No. 3:13-cv-10791-DRH-PMF in the U.S. District Court for the Southern District of Illinois. It has been added to the Yasmin/Yaz blood clot MDL known as In Re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Relevant Liability, MDL No. 2100, in the U.S. District Court for the Southern District of Illinois.
If you’ve suffered from serious complications after using a drospirenone-based birth control pill like Yaz or Yasmin, you may have had your life completely turned upside down. Blood-clot related complications like strokes or pulmonary embolism can require serious medical intervention – along with the medical costs and lost wages from recovery time that entails. Some patients, despite the best efforts of medical professionals, may suffer from life-long complications, like blindness and brain damage that can severely impact your quality of life. These burdens can sometimes fall on their family, either for caring for a disabled family member or coping with the loss of a loved one.
Regardless of the situation you’ve found yourself facing, you need to remember that you still have rights, and there are steps that you can take to regain a measure of control over your situation. You can start by visiting the Yaz/Yasmin, Beyaz & Ocella Birth Control Pill Class Action Lawsuit Settlement & Investigation. Here, you can enter information about your situation for a free review by a legal expert with a background in this type of litigation. From here, you can receive additional guidance on the best steps to take in your specific legal situation.
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
One thought on New Yaz Blood Clot Lawsuit Joins MDL against Bayer